salicyloxazolines in the presence of NaOMe gives complexes [RhCl(R-saloxaz)Cp*] (1–4) which have been fully characterised. The diastereoselectivity of complexation depends on the substituents and the absolute configuration at the metal centre is unstable in solution. Treatment of 2 with 4-methylpyridine and NaSbF6 in methanol at reflux gave [Rh(4-Mepy)(S)-iPr-saloxaz}Cp*][SbF6] (5) whilst [Rh(OH2)(Me2-saloxaz)Cp*][SbF6]
[的RhCl的反应2的CP *] 2(CP * =η-C 5我5),在加入NaOMe存在salicyloxazolines给出配合物[的RhCl(R-saloxaz)的CP *](1 - 4),其已被完全表征。络合的非对映选择性取决于取代基,并且
金属中心的绝对构型在溶液中不稳定。用4-
甲基吡啶和NaSbF 6在
甲醇中回流处理2,得到[Rh(4-Mepy)(S)-i Pr-saloxaz} CP *] [SbF 6 ](5)而[Rh(OH 2)( Me 2 -saloxaz)CP *] [SbF 6](6)是通过1与AgSbF 6反应制备的。三种络合物,[RhCl(Me 2 -saloxaz)CP *](1),[RhCl (S)-i Pr-saloxaz} CP *](2)和[Rh(OH 2)(Me 2 -saloxaz) CP *] [SbF 6 ](6)已通过X射线晶体学表征。在用AgSbF